• Tamprint 300, a new revolution in super fast printing technology  for higher output needs.
  • Servo driven system giving centered print by vacuum hold arrangement  for individual product, during ink transfer.
  • Color display on IPC with easy operator friendly controls.
  • Can work on various types of products coated with aqueous coating, non-aqueous coating besides sugar or enteric coating.
  • Any size of product can be used for printing. Quick change over and easy maintenance.
  • In built UPS for smooth functioning and shut down in power failure condition.
  • Print on maximum surface area of product with specially designed silicon pad.
  • Special heating system for drying the ink. Equipped with Siemens control system.
  • All product contact parts are SS 316L /  PVC.

High Shear Mixer Granulator - R2T

• Increase in productivity due to unique R2T technology (Upto almost 50%, as per data shared by customers)
• Greater accuracy in determining and validating granulation endpoint
• Superior performance of the machine with 100% accuracy, due to Direct Drive Motor
• Improved Efficiency as minimal maintenance needs, due to elimination of conventional machine components such as, belts, pulley drives, worm & worm wheel gearbox, etc.
• Reduced number of batches for validation of product to commercial level, due to precise Granulation endpoint
• Major savings and cost containment due to absence of drive elements, improved efficiency of 85% and savings in power bills upto 12%
• Meets all requirements of cGMP

Rusty Nelson

(630) 776 - 2459

Go to article: Home | Gut InstinctGo to article: In this issueGo to article: TSS Company InsightGo to article: TSS ABGo to article: International Cannabis and Cannabinoid Institute (ICCI) Company InsightGo to article: International Cannabis and Cannabinoid Institute (ICCI)Go to article: ContentsGo to article: Daiichi JitsugyoGo to article: NewsGo to article: Scandinavian Health Ltd.Go to article: The Pharma Industry BriefingGo to article: Komtur PharmaceuticalsGo to article: Komtur Pharmaceuticals Company InsightGo to article: How will the UK’s relaxed cannabis regulations impact clinical practice?Go to article: Finnair CargoGo to article: Finnair Cargo | Company InsightGo to article: Developing a new class of cancer combo drugsGo to article: Phoenix Company InsightGo to article: PhoenixGo to article: Antidepressants in the environment: combatting pharmaceutical pollutionGo to article: AtoZ-CRO GmbHGo to article: AtoZ-CRO GmbH Company InsightGo to article: Christensella: the key to unlocking gut microbiome-based drug discovery?Go to article: CBDepotGo to article: CBDepot Company InsightGo to article: Going digital to improve clinical trial enrolmentGo to article: BEAGo to article: Incretin combination therapy: a breakthrough for type 2 diabetes?Go to article: AlpexGo to article: Ebola in the DRC: vaccinating in a conflict zoneGo to article: Hemp IndustriesGo to article: Unither PharmaceuticalsGo to article: Data overload: turning challenges into opportunities in clinical trialsGo to article: ZenatekGo to article: Solving clinical research challenges: an IT perspectiveGo to article: Pfanstiehl Company InsightGo to article: PfanstiehlGo to article: EventsGo to article: In the next issue